Data / Form D filings / iXpressGenes, Inc.
iXpressGenes, Inc.: Form D filing
iXpressGenes, Inc., a biotechnology company in Huntsville, AL, filed a Form D with the SEC in 2025. The latest, on June 26, 2025, reports $2.4 million sold of a $4.2 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 601 GENOME WAY NORTHWEST, Huntsville, AL, 35806
- Phone
- (256) 327-9750
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Alabama
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2074283
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 26, 2025 | New notice | $4,184,000 | $2,370,000 | $1,814,000 | 13 | Sep 16, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peggy Sammon | Director | |
| John Schmitt | Executive Officer, Director | |
| Barbara Fisk | Director | |
| Joseph Ng | Executive Officer, Director |
Other biotechnology companies in Alabama that filed recently
- Khaya Biosciences, Inc. $200,000 · Aug 13, 2026
Every Form D from the week of Jun 23, 2025 · All recent filings in Alabama · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what iXpressGenes, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.